CTRI/2022/04/042186招募中未知
Randomized controlled trial to compare the effect of dietary intervention and resistance exercises on changes in skeletal muscle strength, mass and function in Type 2 Diabetes patients with Dynapenia and Sarcopenia
试验速览
- 阶段
- 未知
- 状态
- 招募中
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
入选标准
- •?Patients age between 18-60yrs.
- •?Patients diagnosed with Type -2 DM. Along with Sarcopenic
- •?Hand grip strength Men <28 kg, Women <18 kg
- •?Appendicular skeletal muscle mass/height2: Men <7.0kg/m2, Women <5.4 kg/m2.
- •?SPPB=8 (The maximum score on the SPPB is:12)
- •?4-minute gait speed <0.8m/s.
排除标准
- •?Patient with concomitant severe heart, liver or renal diseases.
- •?Pregnancy and Lactation, and any physical deformity or loss of extremity.
- •?HIV, HbsAg and HCV positive patients.
研究者
相似试验
进行中（未招募）
3 期
A clinical trial comparing daily versus intermittent vitamin D supplementation in children with nephrotic syndromeCTRI/2020/04/024598Jawaharlal Nehru medical college
尚未招募
不适用
A study of the effect of fentanyl boluses versus infusion on surgical plethysmographic index during surgeryCTRI/2020/11/029056Kasturba Medical College
进行中（未招募）
不适用
Repeated application of bone marrow-derived stem cells to treat chronicpost-infarction heart failureChronic post-infarction heart failure due to an at least 3 months old myocardial infarction, treated with optimal medication according to the evidence-based guidelines, in NYHA stadium II-IIIand with open vessel / bypass sullpying the previously infarcted areaEUCTR2011-000595-33-NLGoethe University Frankfurt676
招募中
3 期
Randomized controlled trial to compare the effects of single versus repeated intracoronary application of autologous bone marrow-derived mononuclear cells on total and SHFM-predicted mortality in patients with chronic post-infarction heart failure;REpetitive Progenitor cEll therapy in Advanced chronic hearT failure (REPEAT trial)10019280Heart failureNL-OMON47617Goethe University Frankfurt20
进行中（未招募）
1 期
Repeated application of bone marrow-derived stem cells to treat chronic post-infarction heart failureChronic post-infarction heart failure due to an at least 3 months old myocardial infarction, treated with optimal medication according to the evidence-based guidelines, in NYHA stadium II-IIIand with open vessel / bypass sullpying the previously infarcted areaEUCTR2011-000595-33-DEGoethe University Frankfurt676